Clinical Trials
2
Active:0
Completed:2
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)β’ Click on a phase to view related trials
Phase 1
2 (100.0%)A Safety and Immunogenicity of Intranasal Nanoemulsion Adjuvanted Recombinant Pandemic Flu Vaccine in Healthy Adults
Phase 1
Completed
- Conditions
- Influenza, Pandemic
- First Posted Date
- 2022-05-31
- Last Posted Date
- 2024-08-22
- Lead Sponsor
- BlueWillow Biologics
- Target Recruit Count
- 40
- Registration Number
- NCT05397119
- Locations
- πΊπΈ
Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, United States
A Safety and Immunogenicity of Intranasal Nanoemulsion Adjuvanted Recombinant Anthrax Vaccine in Healthy Adults
Phase 1
Completed
- Conditions
- Anthrax
- First Posted Date
- 2019-11-01
- Last Posted Date
- 2022-05-18
- Lead Sponsor
- BlueWillow Biologics
- Target Recruit Count
- 84
- Registration Number
- NCT04148118
- Locations
- πΊπΈ
Johnson County Clin-Trial, Lenexa, Kansas, United States
News
No news found